In May 2023, the latest set of guidance (List 3) of the Evidence-based Interventions (EBI) Programme was published. The program is run by the Academy of Medical Royal Colleges (AoMRC), supported by NHS England and NICE. Ten procedures were added to the List across a range of medical specialties, including breast surgery, gastrointestinal surgery, cardiovascular, urology, and ophthalmology. It is expected that where treatment criteria outlined in the List for the intervention are met, it would be routinely funded.

On June 5, 2023, the updated version of the Laboratory test nomenclature was published by the Finnish Institute for Health and Welfare (THL) to come into force on July 1, 2023. A total of 138 new codes were introduced.

On June 6, 2023, Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) introduced a new convention to reimburse aspirational and mechanical thrombectomy catheters for arterial thrombosis, deep vein thrombosis, arteriovenous fistula, and pulmonary embolism. Funding will only be provided if there is a shortage of thrombolytic drugs in Belgium.

MTRC offers a new service of paid hourly consultations by the Director, Dr Oleg Borisenko. Normally, MTRC works on a project basis with a fixed budget. However, the format of the project does not fit all our clients. Sometimes, instead of a project, a one-two-hour consultation can be sufficient to guide the company in the right direction in relation to European market access, evidence generation and other related topics. MTRC now offers the possibility of hourly paid consultations with Oleg Borisenko, one of the most knowledgeable experts in European Med Tech market access. Read about typical situations for such support and conditions in this post.

We are happy to announce the further expansion of our HEOR Department with Sandeep Moola, an Evidence Synthesis Specialist. Sandeep holds a Master’s degree in Health Services Management with Honors Care from Griffith University, Brisbane, Australia (2006) and a Master’s degree in Philosophy (Clinical Science) in Evidence-Based Health Care from the University of Adelaide, Australia (2012), and he has a Ph.D. degree in Evidence-Based Health Care from the University of Adelaide, Australia (2017). Sandeep has extensive experience working for one of the world’s leading organizations on evidence-based medicine, Joanna's Briggs Institute in Australia.

On June 1, 2023, NHS England issued an updated version of the National Genomic Test Directory, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Three new codes (test-indication combinations) were introduced in the Test Directory for rare and inherited diseases.

On May 25, 2023, the Dutch Organization for Health Research and Development (ZonMw) initiated submission of applications for research into the effectiveness and costs of interventions (diagnostic and therapeutic) under the 2025 Incentive subsidy round of the Efficiency Research program. The deadline for submission of applications is September 5, 2023.

The “New Methods” framework invited interested parties to submit information regarding microcurrent treatment for anxiety, depression, and sleep problems before August 8, 2023. Ordering Forum will then decide whether the method will undergo evaluation at the national level.

On June 7, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the overview of thirty-five newly funded healthcare research projects. These projects relate to the two funding announcements of June 27, 2022 (changed on September 20, 2022).

On June 5, 2023, the application window for submitting applications for changes in the Swiss nomenclature of surgical procedures (CHOP), as well as for the SwissDRG system, was open. The deadline for submission of CHOP applications is September 17, while the deadline for SwissDRG submissions is July 17.

In May 2023, the National Institute for Health and Care Research (NIHR) in England released two MedTech-related reports in its Health Technology Assessment (HTA) Journal, which endoscopic radiofrequency ablation in malignant biliary obstruction and screening for ovarian cancer. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

On June 01, 2023, the French National Authority for Health (HAS) announced the start of the application period for the evaluation of procedures and IVD tests to be included in 2024 HAS working program.